Clinical Trials Browser

Observational × darolutamide × 30 days × Clear all

NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Prostatic Neoplasms

NCT06334120 2026-03-12

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Non-metastatic Castration-resistant Prostate Cancer

NCT06724159 2026-02-17

SOGUG-PRINCIS

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms